Featured News

COMPANY

First Lady of Virginia visits AMPEL

First Lady of Virginia visits AMPEL

Suzanne Youngkin shared the goals of the W+g initiative focused on wellbeing and workforce in Virginia during her March 30th visit to AMPEL BioSolutions, a women-owned business founded, headquartered and growing in Charlottesville.  The focus of AMPEL's business is...

read more
Charlottesville-area company receives praise for internship program

Charlottesville-area company receives praise for internship program

AMPEL BioSolutions, LLC. is being recognized by Virginia officials for its internship program. It is the only tech company in Charlottesville recognized this cycle. AMPEL says its priority is contributing to knowledge of the future. Interns are able to examine RNA, work on projects, and provide design support for doctors

read more

PLATFORM

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

PRODUCTS

LuGENE Launches in LA: Podcast with Dr. Dan Wallace

This #NewsFromTheLab session welcomes the creators of the new LuGENE lab test by Ampel BioSolutions! Watch Dr. Amrie Grammer and Dr. Peter Lipsky share about the cutting-edge LuGENE® Blood Test, a revolutionary tool designed to predict flare activity and drug targets in lupus, offering new hope and possibilities for patients.

read more
New blood test predicts flares before they happen

New blood test predicts flares before they happen

Ampel Biosolutions announced the launch of LuGENE®, a blood test that uses artificial intelligence (AI) to look at a patient’s gene activity and predict when lupus flares are likely to happen and which medications could be most effective to keep symptoms in check.

read more
New Blood Test Poised to Revolutionize Care for Systemic Lupus Erythematosus

New Blood Test Poised to Revolutionize Care for Systemic Lupus Erythematosus

AMPEL BioSolutions announced the launch of LuGENE®, an exciting breakthrough innovation in systematic lupus erythematosus (SLE) care. LuGENE® is a new blood test designed to predict SLE flares before they happen and provide specific information about each individual’s disease abnormalities, leading to faster, evidence-based treatment.

read more

PARTNERS

Pin It on Pinterest